GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (STU:BVF) » Definitions » Research & Development

Bausch Health (STU:BVF) Research & Development : €561 Mil (TTM As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Bausch Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bausch Health's Research & Development for the three months ended in Mar. 2025 was €132 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was €561 Mil.

Bausch Health Research & Development Historical Data

The historical data trend for Bausch Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Research & Development Chart

Bausch Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.85 418.61 499.38 553.87 588.28

Bausch Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 138.92 144.92 145.06 138.48 132.28

Bausch Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €561 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health  (STU:BVF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bausch Health Research & Development Related Terms

Thank you for viewing the detailed overview of Bausch Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (STU:BVF) » Definitions » Research & Development
Comparable Companies
XCNQ:GTII XCNQ:TRUL TSX:CRON TSX:CURA TSX:DHT.U NEOE:GLAS.A.U TSX:GUD TSX:ACB TSX:WEED NEOE:VRNO ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
BHC:USA BHC:Canada
Address
2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Website
https://www.bauschhealth.com
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health Headlines

No Headlines